FR2433943A1 - Preparations medicamenteuses notamment pour le traitement de l'hypercholesterolemie - Google Patents

Preparations medicamenteuses notamment pour le traitement de l'hypercholesterolemie

Info

Publication number
FR2433943A1
FR2433943A1 FR7815888A FR7815888A FR2433943A1 FR 2433943 A1 FR2433943 A1 FR 2433943A1 FR 7815888 A FR7815888 A FR 7815888A FR 7815888 A FR7815888 A FR 7815888A FR 2433943 A1 FR2433943 A1 FR 2433943A1
Authority
FR
France
Prior art keywords
hypercholesterolemia
treatment
drug preparations
preparations especially
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR7815888A
Other languages
English (en)
Inventor
Max Schibli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Berema SA
Original Assignee
Berema SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berema SA filed Critical Berema SA
Publication of FR2433943A1 publication Critical patent/FR2433943A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention se rapporte à une nouvelle préparation médicamenteuse ayant une activité thérapeutique notamment contre l'hypercholestérolémie et l'hyperlipidémie. Cette préparation comprend comme produit actif au moins un composé de formule :
FR7815888A 1977-06-03 1978-05-29 Preparations medicamenteuses notamment pour le traitement de l'hypercholesterolemie Pending FR2433943A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB23722/77A GB1587638A (en) 1977-06-03 1977-06-03 Iodophenoxyphenylalkenoic acid derivatives and pharmaceutical preparations containing them

Publications (1)

Publication Number Publication Date
FR2433943A1 true FR2433943A1 (fr) 1980-03-21

Family

ID=10200238

Family Applications (4)

Application Number Title Priority Date Filing Date
FR7815888A Pending FR2433943A1 (fr) 1977-06-03 1978-05-29 Preparations medicamenteuses notamment pour le traitement de l'hypercholesterolemie
FR8219399A Expired FR2520230B1 (fr) 1977-06-03 1982-11-19 Preparations medicamenteuses contenant un derive d'acide tetraiodothyro-carboxylique notamment pour le traitement de l'hypercholesterolemie
FR8219398A Expired FR2515962B1 (fr) 1977-06-03 1982-11-19 Preparations medicamenteuses contenant un derive d'acide tetraiodothyrocarboxylique notamment pour le traitement de l'hypercholesterolemie
FR8219401A Expired FR2515961B1 (fr) 1977-06-03 1982-11-19 Preparations medicamenteuses contenant un derive d'acide tetraiodothyrocarboxylique notamment pour le traitement de l'hypercholesterolemie

Family Applications After (3)

Application Number Title Priority Date Filing Date
FR8219399A Expired FR2520230B1 (fr) 1977-06-03 1982-11-19 Preparations medicamenteuses contenant un derive d'acide tetraiodothyro-carboxylique notamment pour le traitement de l'hypercholesterolemie
FR8219398A Expired FR2515962B1 (fr) 1977-06-03 1982-11-19 Preparations medicamenteuses contenant un derive d'acide tetraiodothyrocarboxylique notamment pour le traitement de l'hypercholesterolemie
FR8219401A Expired FR2515961B1 (fr) 1977-06-03 1982-11-19 Preparations medicamenteuses contenant un derive d'acide tetraiodothyrocarboxylique notamment pour le traitement de l'hypercholesterolemie

Country Status (3)

Country Link
CH (1) CH630803A5 (fr)
FR (4) FR2433943A1 (fr)
GB (1) GB1587638A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284971A (en) * 1992-07-16 1994-02-08 Syntex (U.S.A.) Inc. 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007330A1 (fr) * 1989-01-06 1990-07-12 The Regents Of The University Of California Procede de selection de composes pharmaceutiques specifiques utiles
US5643586A (en) * 1995-04-27 1997-07-01 Perricone; Nicholas V. Topical compositions and methods for treatment of skin damage and aging using catecholamines and related compounds
EP0831769B2 (fr) * 1995-06-07 2008-07-23 Lavin, Dr., Thomas N. Utilisations innovantes d'hormones thyroidiennes ou de composes ressemblant a des hormones thyroidiennes
AU4625901A (en) * 2001-03-19 2001-10-03 Topic Empreendimentos E Participacoes S/C Ltda. Pharmaceutical composition of carrier substance for products based on vitamin-E,bromeline and hyaluronidase

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE566423A (fr) *
FR2354101A1 (fr) * 1976-06-10 1978-01-06 Berema Sa Preparation pour traiter les surcharges graisseuses et les infiltrats cellulitiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985892A (en) * 1971-04-15 1976-10-12 Jouveinal S.A. Pharmaceutical preparation for percutaneous treatment of local edemas employing acetazolamide
FR2356427A2 (fr) * 1976-07-02 1978-01-27 Ana Laboratoires Nouveaux medicaments pour le traitement des surcharges lipidiques et de la cellulite

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE566423A (fr) *
FR2354101A1 (fr) * 1976-06-10 1978-01-06 Berema Sa Preparation pour traiter les surcharges graisseuses et les infiltrats cellulitiques

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 76, 14 février 1972, page 124, no. 31759c, Columbus, Ohio, US; H. GOUDONNET et al.: "Inhibiting effect of some iodothyronines and certain of their structural analogs on alcohol dehydrogenase activity" C.R. SOC. BIOL. 1970, 164 (10), 1970-5 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284971A (en) * 1992-07-16 1994-02-08 Syntex (U.S.A.) Inc. 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents

Also Published As

Publication number Publication date
FR2515961B1 (fr) 1986-07-18
FR2520230A1 (fr) 1983-07-29
FR2515962B1 (fr) 1986-07-18
FR2515961A1 (fr) 1983-05-13
FR2515962A1 (fr) 1983-05-13
CH630803A5 (en) 1982-07-15
GB1587638A (en) 1981-04-08
FR2520230B1 (fr) 1986-07-18

Similar Documents

Publication Publication Date Title
FR2391210A1 (fr) Derives d'acides quinoleinecarboxyliques et leur utilisation comme agents antibacteriens
FR2393577A1 (fr) Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse
FR2420344A1 (fr) Nouveaux oxime-ethers, leur preparation et leur application therapeutique.
FR2433943A1 (fr) Preparations medicamenteuses notamment pour le traitement de l'hypercholesterolemie
FR2405067A1 (fr) Compositions pharmaceutiques contenant des derives monofonctionnels du psoralene pour le traitement des affections cutanees
ES2062094T3 (es) Derivados del acido parabanico y composiciones farmaceuticas que los contienen.
FR2393579A1 (fr) Agent antiviral et son application au traitement des affections virales
FR2420346A1 (fr) Medicaments contenant des alcenylxanthines et leur procede de preparation
FR2362587A1 (fr) Agents antimicrobie
ES8407009A1 (es) Un procedimiento para preparar -15-desoxiespergualina.
FR2378757A1 (fr) Nor-o-heterocyclo-dehydro-13, 14 prostaglandines, leur procede de preparation et leur application comme medicaments
FR2401143A1 (fr) Nouvelles n-cyano-n'-(2-((4-methyl-5-imidazolyl) - methylthio)ethyl) - n''-alcynylguanidines, leur procede de preparation et medicament les contenant
FR2369837A1 (fr) Derives actifs de l'uree, leur procede de preparation ainsi que les compositions therapeutiques les contenant
FR2391218A1 (fr) Composes d'azacyclyle et procede pour leur preparation et leur application en tant que medicament
FR2383176A1 (fr) Amino aryl triazines 1-2-4 utilisables dans le traitement d'algies diverses
FR2355501A1 (fr) Nouvelles 2-(ethyl 2,2-disubstitue)-imidazolines, utiles notamment pour le traitement du diabete
FR2378741A1 (fr) Acides garyl goxo isovaleriques doues de proprietes antiphlogistiques et antalgiques
OA09665A (fr) Esters d'aminoacides de l'hydroquinone, leur procédé de préparation et compositions pharmaceutiques ou cosmétiques les contenant
FR2381053A1 (fr) Nouvelles oximes derivees de l'acide 3-thiadiazolyl thiomethyl 7-aminothiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
FR2358884A1 (fr) Compositions d'amino-alcools et leur procede de preparation et leur application notamment pour le traitement d'affections buccales
FR2355846A1 (fr) Esters de penicillines utilisables comme medicaments
FR2397418A1 (fr) Esters de penicilline utilisables comme medicaments et procede pour leur preparation
FR2379532A1 (fr) Nouveaux derives de l'acide oxamique, leur preparation et leur application comme medicaments
FR2698789B1 (fr) Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
HUP9903892A2 (hu) Hidroxámsavszármazékok

Legal Events

Date Code Title Description
ER Errata listed in the french official journal (bopi)

Free format text: 17/80